Adagene Inc. (ADAG)
Nasdaq: ADAG · Pharmaceutical Preparations · Jiangsu, CN · filing with the SEC since 2020
Who runs Adagene Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Luo Peter
Chief Executive Officer. First filing Mar 2026, latest Sep 17, 2026, 2 filings in all.
Officers reporting now
6
of 10 people with a filing in the last fifteen months
Directors reporting now
4
10 people on the record since 2026
Officerssales are open-market, Oct 2, 2025 to Oct 2, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Gu Chunfang | Executive Director of Finance | Mar 2026 | Oct 2, 2026 | none |
| Tam Man Kin | Chief Financial Officer | Mar 2026 | Sep 25, 2026 | none |
| Luo Peter | Chief Executive Officer | Mar 2026 | Sep 17, 2026 | none |
| Chane-Du Mickael Yannick | Chief Strategy Officer | Mar 2026 | Mar 18, 2026 | none |
| Zhao Qinghai | Chief Manufacturing Officer | Mar 2026 | Mar 18, 2026 | none |
| Zhou Ling | ED of Human Resources | Mar 2026 | Mar 18, 2026 | none |
Directorssales are open-market, Oct 2, 2025 to Oct 2, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Do Cuong V | director | Mar 2026 | Aug 18, 2026 | none |
| Cheung Andy Yiu Leung | director | Mar 2026 | Aug 17, 2026 | none |
| Zhu Li | director | Mar 2026 | Aug 17, 2026 | none |
| Grawunder Ulf | director | Mar 2026 | Aug 14, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.